Navigation Links
Israel Makov Appointed Chairman of Sun Pharma Board
Date:5/29/2012

MUMBAI, May 29, 2012 /PRNewswire/ --

The Board of Directors of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) met today and announced appointment of Mr Israel Makov as Chairman of the Board.

Mr. Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd (2002-2007). He is among Israel's most respected corporate leaders, and is widely credited with Teva's emergence as a global company and a world leader in generic pharmaceuticals.

Speaking on the induction, Mr Dilip Shanghvi, Managing Director of Sun Pharma said "I welcome Mr Makov on behalf of the entire Board and the larger Sun Pharma team.  He is an exceptional leader with deep knowledge and experience in globalizing businesses successfully.  As Sun Pharma continues to rapidly expand its presence worldwide, I am sure that we will benefit immensely from his experience."

On his appointment, Mr Makov said, "I am happy to accept the position of Chairman of the Board.  Sun Pharma is an exciting company poised for substantial global expansion and I look forward to working together with Dilip and his team in realizing their visionary goals."

Profile of Mr Israel Makov

Mr Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd.  He joined Teva in 1995 and led the company's global expansion, managing over 12 acquisitions - two of which were the largest M&A deals in the Israeli history at the time.  Under Mr Makov's leadership, Teva became the undisputed global leader in generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis.  Prior to joining Teva in 1995, Mr. Makov led a number of companies in various industries, and founded Israel's first biotech company, Interpharm which went public in the US as the first Israeli company in R&D stage.

Currently, Mr Israel Makov is Chairman of Given
'/>"/>

SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
2. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
3. MGuard(TM) Coronary Stent System Approved in Israel
4. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
5. Oxygen Biotherapeutics, Inc. Receives Phase II Trial Approval in Israel
6. Supreme Court of Israel Rules in Favor of Sun Pharma
7. SAFC® Completes Expansion of High-Potency Fermentation Capabilities at Israel Site
8. Robotic Surgery Expert Dr. David Samadi, MD Travels to Israel to Perform a Live Robotic Prostatectomy
9. Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success
10. 2P2D Ltd. Announces the Appointment of Tovi Bachar, Former Managing Director of GE Healthcare Israel, as Director and Chairman
11. Neusoft to Invest in Israeli Medical Solutions Company for Accelerating Expansion in Global Healthcare Service Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation ... to support older adults suffering from the severe ... AARP and its members are committed to helping those ... AARP and AARP Foundation will match dollar-for-dollar contributions up ... aid. The matching program will be administered through AARP ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... 15, 2014 Shire plc (LSE: SHP, ... the Office of Fair Trading (OFT) approval condition to the ... ViroPharma Incorporated (NASDAQ: VPHM).   As a result ... OFT approval, and Shire expects to complete the tender offer ... subject to the satisfaction of all of the remaining conditions ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... 2011 PDI, Inc. (Nasdaq: PDII ), a ... companies, today announced the extension of a contract sales engagement ... began April 1 and will run for the balance of ... PDI of approximately $23 million. Under the program, ...
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
Cached Medicine Technology:PDI Announces Contract Extension With Revenue Value of Approximately $23 Million 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3
(Date:4/14/2014)... the scientific marvels of the 20th century, is currently ... bacterial infections. But scientists at the University of South ... its combat effectiveness, even against so-called "superbugs." , Bacteria ... penicillin family of drugs since their first wide-scale use ... infection, brought about by the bacterium Staphylococcus aureus ...
(Date:4/14/2014)... information on colorectal cancer is too difficult for most ... risks to and concerns of patients, a study by ... review of a dozen popular websites, most of the ... written beyond the recommended sixth-grade reading level, while content ... well as the barriers to and benefits of screening, ...
(Date:4/14/2014)... SOUTH SAN FRANCISCO, Calif.--True North Therapeutics, Inc., announced ... antibody prevents the destruction of human red blood ... a type of autoimmune hemolytic anemia (AIHA). The ... protease C1s, prevents complement activation induced by cold ... the journal Blood earlier this month. ...
(Date:4/14/2014)... Frank Porter Graham Child Development Institute have released ... program to prepare four-year-olds for success in kindergarten. ... Pre-K show significant gains across all areas of ... even greater rate during their participation in NC ... senior scientist Ellen Peisner-Feinberg, who leads the FPG ...
(Date:4/14/2014)... about health that aren,t based on medical evidence are ... research suggests. , In the Ohio State University study, ... as "irrational health beliefs" on a standard measure of ... a prescribed cardiac rehab program. , Among the ... flu vaccine or believing, based on family history alone, ...
Breaking Medicine News(10 mins):Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3
... Kashmir University Wednesday suspended construction of a guesthouse inside the ... following student protests . ,Vice Chancellor Abdul Wahid ... campus here. ,Hundreds of students had launched an ... chinar trees being felled to make way for the construction. ...
... peoples sleep. Some are light sleepers, whereas others sleep ... their time . ,Such sleeping pattern ... circumstances, habits, and other non-biological factors. But now a ... and assistant director of the Sleep and Performance Research ...
... The international HIV and AIDS charity AVERT is today launching ... end to the 380,000 child AIDS deaths and half ... year. ,At this year's G8 summit in Germany, the ... chance to stop child AIDS deaths by committingspecific funds for ...
... breast Cancer treatment comes in the form of Intraoperative ... radiation during surgery . Thus the patient can avoid ... the Princess Margaret Hospital team combined the expertise of ... and nurses to perform its first procedure. It marked ...
... today seems to be disintegrating at an alarming rate. Studies ... one in ten children now has a mental health disorder ... More than a million children have mental health problems, a ... conduct disorders have become twice as common since the 1930s ...
... The Canadian Food Inspection Agency has issued a warning to ... Alberta, Ontario, Quebec and Nova Scotia as it could ... the product has been done by Les Aliments G. Dion. ... the market. ,Salmonella contaminated food does not appear ...
Cached Medicine News:Health News:Individual Differences in Sleep Structure are Biologically Determined 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Intraoperative Radiation Therapy a New Step in Breast Cancer Treatment 2Health News:Mental Health of Children on the Decline 2
... insulin pen with a memory. HumaPen MEMOIR records the ... (including priming doses). You can see exactly when and ... you simply "dial" your dose by turning the dose ... initial set-up. If you dial too many units, you ...
Assay development using client's antibodies and antigens to meet diagnostic target...
Colloidal Gold Conjugated, Streptavidin - 50 OD...
Colloidal Gold Conjugated, Goat anti-rabbit IgG (H&L) - 50 OD...
Medicine Products: